Targeting of CD34⁺CD38^- cells using Gemtuzumab ozogamicin (Mylotarg) in combination with tipifarnib (Zarnestra) in acute Myeloid Leukaemia

by Jawad Mays, Yu Ning, Seedhouse Claire, Tandon Karuna, Russell Nigel H, Pallis Monica
Published 2012-09-01